Second annual report from American Lung Association explores how states can act to save more lives, support patients and families facing lung cancer ANCHORAGE – Alaska ranks near the bottom of the country with the five-year lung cancer survival rate at 17.6 percent. An estimated 400 Alaskans will be diagnosed with lung cancer in 2019, but more […]
Some Alaska residents should consider re-testing their homes for radon after earthquake. ANCHORAGE (January 15, 2019) – Radon is a naturally occurring gas that hides invisibly in homes and is the nation’s second-leading cause of lung cancer. January is National Radon Action Month, and several areas in Alaska have moderate radon levels, according to the Environmental Protection […]
In an unprecedented study conducted at UCLA and 29 other sites worldwide, Keytruda (pembrolizumab) was found to be effective in the treatment of patients with advanced non-small cell lung cancer U.S. Food and Drug Administration has approved the groundbreaking immunotherapy drug Keytruda (pembrolizumab) to treat advanced non-small cell lung cancer (NSCLC) Three-year international study led […]
The U.S. Food and Drug Administration today approved a new drug to treat non-small-cell lung cancer (NSCLC), offering patients new hope in fighting this difficult disease. Lung cancer is expected to lead to over 150,000 deaths in the United States this year alone, and NSCLC accounts for about 85 percent of all lung cancers. The […]